- Home
- WLGS vs SPRC Comparison
WLGS vs SPRC Comparison
Compare WLGS & SPRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WLGS
- SPRC
- Stock Information
- Founded
- WLGS 1981
- SPRC 2004
- Country
- WLGS Hong Kong
- SPRC Israel
- Employees
- WLGS N/A
- SPRC N/A
- Industry
- WLGS Engineering & Construction
- SPRC Biotechnology: Pharmaceutical Preparations
- Sector
- WLGS Consumer Discretionary
- SPRC Health Care
- Exchange
- WLGS Nasdaq
- SPRC Nasdaq
- Market Cap
- WLGS 3.0M
- SPRC 3.0M
- IPO Year
- WLGS 2023
- SPRC N/A
- Fundamental
- Price
- WLGS $0.05
- SPRC $5.14
- Analyst Decision
- WLGS
- SPRC
- Analyst Count
- WLGS 0
- SPRC 0
- Target Price
- WLGS N/A
- SPRC N/A
- AVG Volume (30 Days)
- WLGS 144.7M
- SPRC 41.7K
- Earning Date
- WLGS 08-19-2025
- SPRC 02-15-2025
- Dividend Yield
- WLGS N/A
- SPRC N/A
- EPS Growth
- WLGS N/A
- SPRC N/A
- EPS
- WLGS N/A
- SPRC N/A
- Revenue
- WLGS $3,951,649.00
- SPRC $1,306,000.00
- Revenue This Year
- WLGS N/A
- SPRC N/A
- Revenue Next Year
- WLGS N/A
- SPRC N/A
- P/E Ratio
- WLGS N/A
- SPRC N/A
- Revenue Growth
- WLGS N/A
- SPRC N/A
- 52 Week Low
- WLGS $0.03
- SPRC $4.14
- 52 Week High
- WLGS $9.66
- SPRC $37.59
- Technical
- Relative Strength Index (RSI)
- WLGS 45.71
- SPRC 32.98
- Support Level
- WLGS $0.04
- SPRC $5.06
- Resistance Level
- WLGS $0.08
- SPRC $5.59
- Average True Range (ATR)
- WLGS 0.01
- SPRC 0.48
- MACD
- WLGS 0.00
- SPRC -0.19
- Stochastic Oscillator
- WLGS 17.37
- SPRC 2.90
About WLGS Wang & Lee Group Inc.
WANG & LEE Group Inc operates as an investment holding company. The firm conducts its primary operations through its indirectly wholly owned subsidiary WANG and LEE CONTRACTING LIMITED. WLHK provides contract engineering, installation, and out-fitting of the following products and services: low voltage electrical systems, mechanical ventilation and air-conditioning systems (MVAC), fire safety systems, water supply and sewage disposal systems, and site project management.
About SPRC SciSparc Ltd.
SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.